For complete product information refer to the product insert. Treatment with fewer than 6 monthly doses after the last exposure to mosquitoes may not provide complete heartworm prevention. Mild hypersensitivity reactions have been noted in some dogs carrying a high number of circulating microfilariae. SENTINEL ® SPECTRUM ® Chews (milbemycin oxime/lufenuron/praziquantel). Dogs should be tested for heartworm prior to use. Use with caution in cats with a history of neurologic disorders. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in dogs with a history of seizures or neurologic disorders. Seizures have been reported in dogs receiving isoxazoline class drugs, even in dogs without a history of seizures. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS has not been established in breeding, pregnant, and lactating cats.Īll BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. BRAVECTO Topical Solution for Dogs and Cats and BRAVECTO PLUS for cats are for topical use only. BRAVECTO Chews and Topical Solution for dogs is not effective against the lone star tick beyond 8 weeks of dosing. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.īRAVECTO has not been shown to be effective for 12-weeks’ duration in puppies or kittens less than 6 months of age. Use with caution in cats that are heartworm positive. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. BRAVECTO PLUS Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO Topical Solution for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Dogs: The most commonly reported adverse reactions include vomiting, hair loss, diarrhea, lethargy, decreased appetite, and moist dermatitis/rash. In some cases, adverse events have been reported following use in breeding females. BRAVECTO Chews for Dogs: The most commonly reported adverse reactions include vomiting, lethargy, diarrhea, anorexia and pruritus. americanum in puppies less than 6 months of age. BRAVECTO 1-MONTH is not effective against A. The most commonly reported adverse reactions include itching, diarrhea, vomiting, decreased appetite, elevated ALT, lethargy, and weight loss. 2018 11:581.īRAVECTO 1-MONTH Chews: indicated for dogs 8 weeks of age and older. Freedom of Information Summary, NADA 141-333. Indianapolis, IN: Elanco Animal Health 2012. Freedom of Information Summary, NADA 141-426.
0 Comments
Leave a Reply. |